State Ledger
Company profile

INTELLIGENT BIO SOLUTIONS INC. CIK 1725430

Ticker
INBS (Nasdaq)
Industry
Surgical & Medical Instruments & Apparatus
Headquarters
New York, NY 10036
Fiscal year end
2026 (FY)
Market Data
Close
$1.49
Change
-$0.02
Change %
-1.32%
Volume
138

INBS · trading date Oct 13, 2026 · previous close $1.51 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$4.22M
Net income
-$12.43M
Total assets
$11.94M
Total liabilities
$6.65M
Stockholders' equity
$5.51M
Cash & equivalents
$3.99M
Operating income
-$12.61M
Operating cash flow
-$11.93M
Capital expenditures
$125.7K

Fiscal year 2026, via 10-K filed 2026-08-19. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-299.1%
Net margin
-294.9%
Free cash flow
-$12.05M
Free cash flow margin
-285.9%
Liabilities / assets
55.7%
Equity / assets
46.1%
CapEx / revenue
3.0%
Operating cash flow / net income
0.96×

Derived from the fiscal year 2026 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2026 $4.22M -$12.43M $11.94M $6.65M $5.51M
2025 $3.05M -$10.57M $8.25M $5.44M $3.00M
2024 $3.11M -$10.16M $13.78M $5.60M $8.33M
2023 $1.26M -$10.63M $10.35M $6.67M $3.80M
2022 $437.1K -$8.31M $12.35M $5.81M $6.62M
Company Details
SIC code
3841
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form S-3
2026-09-15
Financials filed via
Form 10-K
filed 2026-08-19

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
New York, NY 10036
135 W 41ST ST,
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:45 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New York — Public Companies